₹19.22
+0.17 (+0.89%)
As of 18 Sept 2026, Kabra Drugs Ltd share price is ₹19.22. The stock opened at ₹19.22 and had closed at ₹19.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹15.50 and a high of ₹35.52. In terms of performance, Kabra Drugs Ltd share price has decreased by 28.84% over the past six months and has decreased by 0.88% over the last year.
Kabra Drugs Stock Price Chart
Kabra Drugs Ltd Overview
Market cap₹46 Crs
Volume64,188
Prev. Close₹19.05
Year range₹15.50 - ₹35.52
ISININE323K01017
About Kabra Drugs
Kabra Drugs is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
Kabra Drugs Ltd Historical Performance
1 Month Return-20.68%
6 Month Return-33.12%
3 Year Return500.62%
3 Month Return-24.42%
1 Year Return3.72%
5 Year Return255.93%
Kabra Drugs Ltd Fundamentals
ROCE(TTM)19.05%
P/E Ratio (TTM)6.01
P/B Ratio1.54
Debt to Equity0.02
ROE16.75%
EPS (TTM)3.20
Dividend Yield0.00%
Book Value12.49
Profit Margin5.76%
Operating Margin6.48%
Kabra Drugs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 93.23 | 0.64 | - | 0.01 | - |
| EBITDA | 5.82 | -1.08 | -0.74 | -0.34 | -0.18 |
| Net Profit | 4.96 | -1.09 | -0.74 | -0.34 | -0.19 |
| EPS | 2.09 | -0.99 | -1.68 | -0.77 | -0.42 |
Kabra Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 18.41 |
| Resistance 1 (R1) | 19.82 |
| Pivot Point | 19.17 |
Kabra Drugs Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| N Aravind | Managing Director |
| Venkatakrishnappa Ananth Kumar | Whole Time Director |
| KUNIAMUTHUR NANJAPPAN ANAND | Executive Directorector |
Kabra Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Kabra Drugs Ltd today is ₹19.22 on NSE and ₹19.22 on BSE.
- The 52-week high of Kabra Drugs Ltd is ₹35.52, while the 52-week low is ₹15.50.
- The current market capitalisation of Kabra Drugs Ltd is approximately ₹46 crore.
- The P/E (Price-to-Earnings) ratio of Kabra Drugs Ltd is 6.01. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Kabra Drugs Ltd is 1.54. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Kabra Drugs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Kabra Drugs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Kabra Drugs Ltd has delivered a return of approximately 500.62%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Kabra Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 0.00% promoters, 0.00% FIIs, 0.00% DIIs, and 90.69% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
